(NYSE: PBH) Prestige Consumer Healthcare's forecast annual revenue growth rate of 1.59% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 4.43%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.62%.
Prestige Consumer Healthcare's revenue in 2025 is $1,137,762,000.On average, 5 Wall Street analysts forecast PBH's revenue for 2026 to be $55,147,010,671, with the lowest PBH revenue forecast at $54,356,177,700, and the highest PBH revenue forecast at $57,024,571,878. On average, 5 Wall Street analysts forecast PBH's revenue for 2027 to be $56,526,669,290, with the lowest PBH revenue forecast at $55,764,496,850, and the highest PBH revenue forecast at $58,161,110,139.
In 2028, PBH is forecast to generate $59,479,494,522 in revenue, with the lowest revenue forecast at $59,396,477,814 and the highest revenue forecast at $59,562,511,230.